Kenvue Inc. (KVUE)
Kenvue Inc. operates in the Household & Personal Products industry of the Consumer Defensive sector, headquartered in Summit, NJ, US. The stock last traded at $18.97, down 0.42% on the session, giving a market capitalisation of $36.42B. On trailing twelve-month figures it carries a trailing P/E of 21.80, a net margin of 10.8%. Its beta of 0.43 implies it has historically moved less than the broad market.
Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
Kenvue Inc. is most often compared with the following Consumer Defensive names: